{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:37:50Z","timestamp":1792787870565,"version":"4.5.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T00:00:00Z","timestamp":1782950400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T00:00:00Z","timestamp":1790035200000},"content-version":"vor","delay-in-days":82,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Beijing Geriatric Hospital Key Specialty\/Discipline Construction Fund","id":[{"id":"https:\/\/ror.org\/010ern194","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Research Funds of Beijing Geriatric Hospital","award":["Grant No. 2021bjlnyy-zd-1"],"award-info":[{"award-number":["Grant No. 2021bjlnyy-zd-1"]}],"id":[{"id":"https:\/\/ror.org\/010ern194","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Neurol"],"DOI":"10.1186\/s12883-026-05138-3","type":"journal-article","created":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T06:13:33Z","timestamp":1782972813000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Association of low-dose intra-arterial plus intravenous tirofiban with improved functional outcome in branch atheromatous disease-related stroke patients with early neurological deterioration"],"prefix":"10.1186","volume":"26","author":[{"given":"Xinxiu","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miao","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7722-6986","authenticated-orcid":false,"given":"Zhiyong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,2]]},"reference":[{"key":"5138_CR1","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.jns.2011.01.008","volume":"303","author":"MW Kwan","year":"2011","unstructured":"Kwan MW, Mak W, Cheung RT, Ho SL. Ischemic stroke related to intracranial branch atheromatous disease and comparison with large and small artery diseases. J Neurol Sci. 2011;303:80\u20134.","journal-title":"J Neurol Sci"},{"key":"5138_CR2","doi-asserted-by":"publisher","first-page":"8","DOI":"10.5853\/jos.2014.16.1.8","volume":"16","author":"BJ Kim","year":"2014","unstructured":"Kim BJ, Kim JS. Ischemic stroke subtype classification: an asian viewpoint. J Stroke. 2014;16:8\u201317.","journal-title":"J Stroke"},{"key":"5138_CR3","doi-asserted-by":"publisher","first-page":"1851","DOI":"10.1007\/s10072-015-2267-1","volume":"36","author":"Z Duan","year":"2015","unstructured":"Duan Z, Fu C, Chen B, Xu G, Tao L, Tang T, et al. Lesion patterns of single small subcortical infarct and its association with early neurological deterioration. Neurol Sci. 2015;36:1851\u20137.","journal-title":"Neurol Sci"},{"key":"5138_CR4","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1161\/STROKEAHA.114.007466","volume":"46","author":"HG Jeong","year":"2015","unstructured":"Jeong HG, Kim BJ, Yang MH, Han MK, Bae HJ. Neuroimaging markers for early neurologic deterioration in single small subcortical infarction. Stroke. 2015;46:687\u201391.","journal-title":"Stroke"},{"key":"5138_CR5","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.jocn.2016.04.011","volume":"33","author":"MG Park","year":"2016","unstructured":"Park MG, Oh EH, Kim BK, Park KP. Intravenous tissue plasminogen activator in acute branch atheromatous disease: Does it prevent early neurological deterioration? J Clin Neurosci. 2016;33:194\u20137.","journal-title":"J Clin Neurosci"},{"key":"5138_CR6","doi-asserted-by":"publisher","first-page":"581","DOI":"10.3389\/fneur.2020.00581","volume":"11","author":"X Wu","year":"2020","unstructured":"Wu X, Liu Y, Nie C, Kang Z, Wang Q, Sun D, et al. Efficacy and Safety of Intravenous Thrombolysis on Acute Branch Atheromatous Disease: A Retrospective Case-Control Study. Front Neurol. 2020;11:581.","journal-title":"Front Neurol"},{"key":"5138_CR7","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1136\/jnnp-2014-308327","volume":"86","author":"P Seners","year":"2015","unstructured":"Seners P, Turc G, Oppenheim C, Baron JC. Incidence, causes and predictors of neurological deterioration occurring within 24\u00a0h following acute ischaemic stroke: a systematic review with pathophysiological implications. J Neurol Neurosurg Psychiatry. 2015;86:87\u201394.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"5138_CR8","doi-asserted-by":"publisher","first-page":"2396","DOI":"10.1007\/s00415-018-8998-1","volume":"265","author":"X Yi","year":"2018","unstructured":"Yi X, Zhou Q, Wang C, Lin J, Chai Z. Aspirin plus clopidogrel may reduce the risk of early neurologic deterioration in ischemic stroke patients carrying CYP2C19*2 reduced-function alleles. J Neurol. 2018;265:2396\u2013403.","journal-title":"J Neurol"},{"key":"5138_CR9","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1001\/jamaneurol.2024.0146","volume":"81","author":"HS Chen","year":"2024","unstructured":"Chen HS, Cui Y, Wang XH, Ma YT, Han J, Duan YJ, et al. Clopidogrel Plus Aspirin vs Aspirin Alone in Patients With Acute Mild to Moderate Stroke: The ATAMIS Randomized Clinical Trial. JAMA Neurol. 2024;81:450\u201360.","journal-title":"JAMA Neurol"},{"key":"5138_CR10","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1007\/s40265-019-01078-0","volume":"79","author":"M Yang","year":"2019","unstructured":"Yang M, Huo X, Miao Z, Wang Y. Platelet Glycoprotein IIb\/IIIa Receptor Inhibitor Tirofiban in Acute Ischemic Stroke. Drugs. 2019;79:515\u201329.","journal-title":"Drugs"},{"key":"5138_CR11","doi-asserted-by":"publisher","first-page":"1402","DOI":"10.1161\/01.STR.31.6.1402","volume":"31","author":"T Abumiya","year":"2000","unstructured":"Abumiya T, Fitridge R, Mazur C, Copeland BR, Koziol JA, Tschopp JF, et al. Integrin alpha(IIb)beta(3) inhibitor preserves microvascular patency in experimental acute focal cerebral ischemia. Stroke. 2000;31:1402\u20139. discussion 1409\u20131410.","journal-title":"Stroke"},{"key":"5138_CR12","doi-asserted-by":"publisher","first-page":"3481","DOI":"10.1161\/STROKEAHA.119.026240","volume":"50","author":"C Wu","year":"2019","unstructured":"Wu C, Sun C, Wang L, Lian Y, Xie N, Huang S, et al. Low-Dose Tirofiban Treatment Improves Neurological Deterioration Outcome After Intravenous Thrombolysis. Stroke. 2019;50:3481\u20137.","journal-title":"Stroke"},{"key":"5138_CR13","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1001\/jamaneurol.2024.0868","volume":"81","author":"W Zhao","year":"2024","unstructured":"Zhao W, Li S, Li C, Wu C, Wang J, Xing L, et al. Effects of Tirofiban on Neurological Deterioration in Patients With Acute Ischemic Stroke: A Randomized Clinical Trial. JAMA Neurol. 2024;81:594\u2013602.","journal-title":"JAMA Neurol"},{"key":"5138_CR14","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1177\/23969873251319151","volume":"10","author":"J Wang","year":"2025","unstructured":"Wang J, Qiao Y, Li S, Li C, Wu C, Wang P, et al. Effects of tirofiban in preventing neurological deterioration in acute ischemic stroke with intracranial artery stenosis: A post hoc analysis of the TREND Trial. Eur Stroke J. 2025;10:919\u201328.","journal-title":"Eur Stroke J"},{"key":"5138_CR15","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1186\/s12883-025-04452-6","volume":"25","author":"Z Zhang","year":"2025","unstructured":"Zhang Z, Liu X, Wang L, Ji X. The effect of remote ischemic conditioning combined with tirofiban on early neurological deterioration in small artery occlusive stroke. BMC Neurol. 2025;25:434.","journal-title":"BMC Neurol"},{"key":"5138_CR16","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1161\/STROKEAHA.120.031738","volume":"52","author":"VHE Chen","year":"2021","unstructured":"Chen VHE, Lee GKH, Tan CH, Leow AST, Tan YK, Goh C, et al. Intra-Arterial Adjunctive Medications for Acute Ischemic Stroke During Mechanical Thrombectomy: A Meta-Analysis. Stroke. 2021;52:1192\u2013202.","journal-title":"Stroke"},{"key":"5138_CR17","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.bbi.2017.11.019","volume":"69","author":"C Chen","year":"2018","unstructured":"Chen C, Li T, Zhao Y, Qian Y, Li X, Dai X, et al. Platelet glycoprotein receptor Ib blockade ameliorates experimental cerebral ischemia-reperfusion injury by strengthening the blood-brain barrier function and anti-thrombo-inflammatory property. Brain Behav Immun. 2018;69:255\u201363.","journal-title":"Brain Behav Immun"},{"key":"5138_CR18","doi-asserted-by":"publisher","first-page":"1993","DOI":"10.1111\/cns.13936","volume":"28","author":"W Guo","year":"2022","unstructured":"Guo W, Xu J, Ma L, Ma J, Li S, Ren C, et al. Safety and efficacy of different tirofiban administration routes on acute ischemic stroke patients with successful recanalization: A propensity score matching analysis. CNS Neurosci Ther. 2022;28:1993\u20132000.","journal-title":"CNS Neurosci Ther"},{"key":"5138_CR19","doi-asserted-by":"publisher","first-page":"e032326","DOI":"10.1161\/JAHA.123.032326","volume":"13","author":"H Li","year":"2024","unstructured":"Li H, Ju D, Tao Z, Wang J, Nguyen TN, Saver JL, et al. Adjunct Intraarterial or Intravenous Tirofiban Versus No Tirofiban After Successful Recanalization of Basilar Artery Occlusion Stroke: The BASILAR Registry. J Am Heart Assoc. 2024;13:e032326.","journal-title":"J Am Heart Assoc"},{"key":"5138_CR20","doi-asserted-by":"publisher","first-page":"e082141","DOI":"10.1136\/bmjopen-2023-082141","volume":"14","author":"S Li","year":"2024","unstructured":"Li S, Zhang D, Sha Y, Zhu Y, Zhou L, Peng B, et al. Efficacy and safety of tirofiban in patients with acute branch atheromatous disease-related stroke (BRANT): a protocol for a randomised controlled trial. BMJ Open. 2024;14:e082141.","journal-title":"BMJ Open"},{"key":"5138_CR21","doi-asserted-by":"publisher","first-page":"3191","DOI":"10.1161\/STROKEAHA.120.032966","volume":"52","author":"KW Nam","year":"2021","unstructured":"Nam KW, Kwon HM, Lee YS. Different Predictive Factors for Early Neurological Deterioration Based on the Location of Single Subcortical Infarction: Early Prognosis in Single Subcortical Infarction. Stroke. 2021;52:3191\u20138.","journal-title":"Stroke"},{"key":"5138_CR22","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1161\/STROKEAHA.123.044334","volume":"55","author":"HJ Jung","year":"2024","unstructured":"Jung HJ, Ryu JC, Joon Kim B, Kang DW, Kwon SU, Kim JS, et al. Time Window for Induced Hypertension in Acute Small Vessel Occlusive Stroke With Early Neurological Deterioration. Stroke. 2024;55:14\u201321.","journal-title":"Stroke"},{"key":"5138_CR23","doi-asserted-by":"publisher","first-page":"2783","DOI":"10.1161\/STROKEAHA.118.022919","volume":"49","author":"Y Wu","year":"2018","unstructured":"Wu Y, Yin C, Yang J, Jiang L, Parsons MW, Lin L. Endovascular Thrombectomy. Stroke. 2018;49:2783\u20135.","journal-title":"Stroke"},{"key":"5138_CR24","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1056\/NEJMoa0804656","volume":"359","author":"W Hacke","year":"2008","unstructured":"Hacke W, Kaste M, Bluhmki E, Brozman M, D\u00e1valos A, Guidetti D, et al. Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N Engl J Med. 2008;359:1317\u201329.","journal-title":"N Engl J Med"},{"key":"5138_CR25","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1056\/NEJMoa1215340","volume":"369","author":"Y Wang","year":"2013","unstructured":"Wang Y, Wang Y, Zhao X, Liu L, Wang D, Wang C, et al. Clopidogrel with aspirin in acute minor stroke or transient ischemic attack. N Engl J Med. 2013;369:11\u20139.","journal-title":"N Engl J Med"},{"key":"5138_CR26","doi-asserted-by":"publisher","first-page":"3289","DOI":"10.1161\/STROKEAHA.117.019193","volume":"48","author":"W Zhao","year":"2017","unstructured":"Zhao W, Che R, Shang S, Wu C, Li C, Wu L, et al. Low-Dose Tirofiban Improves Functional Outcome in Acute Ischemic Stroke Patients Treated With Endovascular Thrombectomy. Stroke. 2017;48:3289\u201394.","journal-title":"Stroke"},{"key":"5138_CR27","doi-asserted-by":"publisher","first-page":"108330","DOI":"10.1016\/j.clineuro.2024.108330","volume":"243","author":"W Li","year":"2024","unstructured":"Li W, Wang K, Zeng C, Huang K, Fu Y, Zhao Z. Safety and efficacy of tirofiban treatment in the endovascular treatment of patients with acute ischaemic stroke - A meta-analysis. Clin Neurol Neurosurg. 2024;243:108330.","journal-title":"Clin Neurol Neurosurg"},{"key":"5138_CR28","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1212\/WNL.39.9.1246","volume":"39","author":"LR Caplan","year":"1989","unstructured":"Caplan LR. Intracranial branch atheromatous disease: a neglected, understudied, and underused concept. Neurology. 1989;39:1246\u201350.","journal-title":"Neurology"},{"key":"5138_CR29","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1159\/000333388","volume":"33","author":"H Hallevi","year":"2012","unstructured":"Hallevi H, Chernyshev OY, El Khoury R, Soileau MJ, Walker KC, Grotta JC, et al. Intracranial atherosclerosis is associated with progression of neurological deficit in subcortical stroke. Cerebrovasc Dis. 2012;33:64\u20138.","journal-title":"Cerebrovasc Dis"},{"key":"5138_CR30","first-page":"402","volume":"25","author":"M Yamada","year":"2004","unstructured":"Yamada M, Yoshimura S, Kaku Y, Iwama T, Watarai H, Andoh T, et al. Prediction of neurologic deterioration in patients with lacunar infarction in the territory of the lenticulostriate artery using perfusion CT. AJNR Am J Neuroradiol. 2004;25:402\u20138.","journal-title":"AJNR Am J Neuroradiol"},{"key":"5138_CR31","doi-asserted-by":"publisher","first-page":"2925","DOI":"10.1161\/STROKEAHA.120.029994","volume":"51","author":"J Yang","year":"2020","unstructured":"Yang J, Wu Y, Gao X, Bivard A, Levi CR, Parsons MW, et al. Intraarterial Versus Intravenous Tirofiban as an Adjunct to Endovascular Thrombectomy for Acute Ischemic Stroke. Stroke. 2020;51:2925\u201333.","journal-title":"Stroke"},{"key":"5138_CR32","doi-asserted-by":"crossref","unstructured":"Zhao L, Jian Y, Li T, Wang H, Lei Z, Sun M et al. The Safety and Efficiency of Tirofiban in Acute Ischemic Stroke Patients Treated with Mechanical Thrombectomy: A Multicenter Retrospective Cohort Study. Biochem Res Int. 2020; 2020:5656173.","DOI":"10.1155\/2020\/5656173"},{"key":"5138_CR33","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1159\/000442577","volume":"41","author":"L Petrone","year":"2016","unstructured":"Petrone L, Nannoni S, Del Bene A, Palumbo V, Inzitari D. Branch Atheromatous Disease: A Clinically Meaningful, Yet Unproven Concept. Cerebrovasc Dis. 2016;41:87\u201395.","journal-title":"Cerebrovasc Dis"}],"container-title":["BMC Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12883-026-05138-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-026-05138-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-026-05138-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T00:29:00Z","timestamp":1790036940000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12883-026-05138-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,2]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["5138"],"URL":"https:\/\/doi.org\/10.1186\/s12883-026-05138-3","relation":{},"ISSN":["1471-2377"],"issn-type":[{"value":"1471-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,2]]},"assertion":[{"value":"10 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the Ethics Committee of Beijing Geriatric Hospital (IRB No. BJLNYY-2021-011) and conducted according to the principles of the Declaration of Helsinki. Written informed consent for data collection was obtained from all participants prior to enrollment. Before IA or IV tirofiban was used, further written informed consent was signed.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"598"}}